FDA Adverse Event Malfunction Summary report: N

ENDOTAK ENDURANCE

MDR report key: 2051990 · Received April 12, 2011

Report

Report Number
2124215-2011-04262
Event Type
Malfunction
Date Received
April 12, 2011
Date of Event
February 21, 2011
Report Date
February 21, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TO DATE, INFORMATION SUGGESTS THAT BOTH OF THESE MEDICAL DEVICES REMAIN ACTIVELY IN SERVICE. AS NEW INFORMATION BECOMES AVAILABLE, THIS REPORT WIL BE FURTHER EVALUATED AND UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS TRANSVENOUS RIGHT VENTRICULAR (RV) LEAD IN ASSOCIATION WITH THE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) DID EXHIBIT GREATER THAN 125 OHMS SHOCK IMPEDANCE ON MULTIPLE OCCASIONS OVER THE PAST MONTH. THERE WAS NO REPORT OF ADVERSE PATIENT SYMPTOM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK ENDURANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0145

Patients

Seq Age Sex Outcome Treatment
1 83 YR 4543| 4471| 4053| 0145| E110| N119| A155| 1831| 4592